Dr. Linda B. Piller

powered by
COS Expertise®
University of Texas Health Science Center at Houston
School of Public Health
Biological Sciences
Assistant ProfessorAppointed: 2001

Mailing Address

The University of Texas Health Science at Houston
School of Public Health
1200 Herman Pressler, E-801
Houston, Texas 77030
United States

Contact Information

Phone: (713) 500-9507
Fax: (713) 500-9530
lpiller@sph.uth.tmc.edu

Qualifications

M.D., University of Texas - Houston Health Science Center, Pathology, 1986.
M.P.H., University of Texas - Houston Health Science Center, Health Services Organization, 1979.
B.S., University of Houston, Education, 1975.

Expertise and Research Interests

I. Cardiovascular Clinical Trial Research.

Monitored and directed endpoints and serious adverse experience reporting, and participant in all phases of clinical trial coordination:

1996 to present: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), sponsored by the National Heart, Lung and Blood Institute (NHLBI):
Director, Endpoints department;
Endpoints Subcommittee;
Medical Management Subcommittee;
Quality Control Subcommittee;
Retention and Adherence Subcommittee;
Bulletin Subcommittee and editorial staff-Participant, Data Safety and Monitoring Board meetings.

1995-1996: Cholesterol and Recurrent Events Trial (CARE), sponsored by Bristol-Myers Squibb Pharmaceutical Research Institute:
Events and Safety Officer;
Endpoints Committee.

II. Curriculum developer and instructor for Pathology and Public Health class at the School of Public Health; offered through Epidemiology and Biological Sciences disciplines.

Other Expertise

Pathologist, training in anatomic and clinical pathology, 1986-1991; practice in anatomic pathology including tissue and cytologic specimens, 1991-1995

Teacher, elementary level, 1976-1980; permanent Texas teacher's certification, grades 1-12

Future Research

In progress:
1. Currently working on a baseline paper for the lipid lowering component of ALLHAT; anticipated submission in fall, 2000
2. Currently working (lead author) on a paper describing the CHF verification process which led to the first major result of ALLHAT in March, 2000; anticipated submission fall, 2000
3. Currently working on a paper describing the operational aspects of termination of one arm of ALLHAT; submission to Controlled Clinical Trials in July, 2000

Keywords

COS Keywords:

Cardiovascular System, Cholesterol, Clinical Trial, Curriculum Development, Heart Diseases, Pathology, Public Health.

Memberships

American Public Health Association
Houston Society of Clinical Pathologists
Society for Clinical Trials
Texas Public Health Association
University of Texas Association of Women Faculty

Previous Positions

1995-2001, Faculty Associate, University of Texas Health Science Center at Houston, School of Public Health, Coordinating Center for Clinical Trials

Publications

  • Pressel SL, Davis BR, Wright JT, Geraci TS, Kingry C, Ford CE, Piller LB, Bettencourt J, Kimmel B, Lusk C, Parks H, Simpson LM, Nwachuku C, Furberg CD, Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), Controlled Clinical Trials, 22(1), 29-41, February 2001 Abstract
  • Plehn JF, Davis BR, Sacks FM, Rouleau JL, Pfeffer MA, Bernstein V, Cuddy TE, Moye LA, Piller LB, Rutherford J, Simpson LM, Braunwald E, Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators, Circulation, 99(2), 216-23, 1999 Abstract

Profile Details

Last Updated: 4/23/2002

COS Expertise ID #424808
Reference this profile directly: http://myprofile.cos.com/piller08